Company: PMVP
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001140361-25-015610
Chunk: 47

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 47
---
798 |     | *          |
| Deepika Jalota, Pharm.D.(8)                                   |     |                   325,907 |     | *          |
| Charles M. Baum, M.D., Ph.D.(9)                               |     |                   124,338 |     | *          |
| Kirsten Flowers(10)                                           |     |                   111,167 |     | *          |
| Carol Gallagher, Pharm.D.(11)                                 |     |                    92,583 |     | *          |
| Richard Heyman, Ph.D.(12)                                     |     |                   340,758 |     | *          |
| Arnold Levine, Ph.D.(13)                                      |     |                   510,456 |     | *          |
| Laurie Stelzer(14)                                            |     |                   127,500 |     | *          |
| All current executive officers and directors (10 persons)(15) |     |                 4,122,447 |     | 7.57%      |

| * | Represents less than 1%. |

| (1) | Based on a Schedule 13D/A filed with the SEC on August 23, 2023 and a Form 4 filed with the SEC on November 24, 2023, consists of 6,475,291 shares held by OrbiMed Private Investments V, LP (“OPI V”). OrbiMed Capital GP V LLC (“OrbiMed GP”) is the general partner of OPI V, pursuant to the terms of the limited partnership agreement of OPI V, and OrbiMed Advisors LLC (“OrbiMed Advisors”) is the managing member of OrbiMed GP, pursuant to the terms of the limited liability company agreement of OrbiMed GP. As a result, OrbiMed Advisors and OrbiMed GP share power to direct the vote and disposition of the shares held by OPI V and may be deemed directly or indirectly, including by reason of their mutual affiliation, to be the beneficial owners of the shares held by OPI V. OrbiMed Advisors exercises this investment and voting power through a management committee comprised of Carl L. Gordon, |

29

TABLE OF CONTENTS

Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPI V. The address of each of the OrbiMed entities, Carl L. Gordon, Sven H. Borho and W. Carter Neild is